Skip to Main Content

Paper Details

Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance.
Epidemics
3
2022
Author NameAffiliation
David A CliftonInstitute of Biomedical Engineering, University of Oxford
David L BuckeridgeMcGill University
  • 1 - 2

Datasets

Release 1.2